Application Deadline: Early admission- May 1st 2020
In case of restrictions connected to the COVID-19 situation, please note that this program has put in place an alternative of long-distance learning. If physical presence is not possible, you will be able to participate in your courses remotely and once permitted, resume them in person without this affecting your ability to complete the program.
During the fall semester, the program will be operating under a hybrid model offering in-person/online classes. If physical presence is not possible, you will be able to participate in your courses remotely and complete your program within the scheduled timeframe. Click here for arrival instructions.
From October 2019, a portion of the M.Sc. and M.P.H. programs are open to international students and courses are taught in English; please look at each specific field of study below. All Ph.D. tracks may be completed in English. M.Sc. students may continue on to a Ph.D., or may transfer to the Direct Ph.D. program within year 1. After B.Sc., eligible students may apply directly to the Ph.D. program.
This program trains researchers in the biomedical fields for work in academic research labs, industry, and hospitals. Students in this program specialize in one or two of the following tracks:
- Cell and Developmental Biology
- Drug Development and Application
- Human Molecular Genetics and Biochemistry
- Microbiology and Clinical Immunology
- Physical Anthropology
- Physiology and Pharmacology
- Epidemiology and Preventive Medicine
The area of specialization is designated on the individual master’s certificate. There is also the option of pursuing master's level research in an affiliated hospital lab. Please see full department list.
Qualified applicants from accredited universities are invited to apply.